Free Trial
CVE:LXG

LexaGene (LXG) Stock Price, News & Analysis

LexaGene logo
C$0.10 -0.03 (-19.23%)
As of 02/21/2023

About LexaGene Stock (CVE:LXG)

Key Stats

Today's Range
C$0.10
C$0.14
50-Day Range
C$0.11
C$0.11
52-Week Range
C$0.07
C$0.31
Volume
2.14 million shs
Average Volume
170,061 shs
Market Capitalization
C$14.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter.

LXG Stock News Headlines

Pamapol Ord Share Price (0LXG)
Biosynex SA ALBIO
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.tc pixel
Cyclopharm Ltd CYC
Lexagene Holdings Inc (LXGh)
Zhejiang Gongdong Medical Technology Co Ltd Class A
IIROC Trading Halt - LXG
See More Headlines

LXG Stock Analysis - Frequently Asked Questions

LexaGene's stock was trading at C$0.11 at the beginning of the year. Since then, LXG shares have increased by 0.0% and is now trading at C$0.11.

Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that LexaGene investors own include Citius Pharmaceuticals (CTXR), Avino Silver & Gold Mines (ASM), Athersys (ATHX), Bionano Genomics (BNGO), EQT (EQT), Inovio Pharmaceuticals (INO) and NIO (NIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
CVE:LXG
CIK
N/A
Fax
N/A
Employees
41
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$8.54 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-339.54%
Return on Assets
-120.21%

Debt

Debt-to-Equity Ratio
138.01
Current Ratio
1.39
Quick Ratio
1.13

Sales & Book Value

Annual Sales
C$110.93 thousand
Price / Sales
133.13
Cash Flow
C$0.00 per share
Price / Cash Flow
21.25
Book Value
C$0.01 per share
Price / Book
10.50

Miscellaneous

Outstanding Shares
140,640,000
Free Float
N/A
Market Cap
C$14.77 million
Optionable
Not Optionable
Beta
2.26
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:LXG) was last updated on 8/20/2025 by MarketBeat.com Staff
From Our Partners